Par 604 (Lamotrigine Extended-Release 250 mg)
Pill with imprint Par 604 is White, Round and has been identified as Lamotrigine Extended-Release 250 mg. It is supplied by Par Pharmaceutical Inc.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Par 604
Lamotrigine Extended-Release
- Imprint
- Par 604
- Strength
- 250 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc.
- National Drug Code (NDC)
- 49884-0604
- Inactive Ingredients
-
methacrylic acid,
hypromelloses,
silicon dioxide
Note: Inactive ingredients may vary.
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,565)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
